A Phase 4 interventional study of Multiple standard of care antibiotics for appendicitis, at physicians' discretion and Multiple standard of care antibiotics for appendicitis, at physicians' discretion in Appendicitis, sponsored by University of California, San Francisco. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by University of California, San Francisco · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 78 studies in Appendicitis with a site in United States — 6 open to participants now, 10 under way, none of them phase 3. Appendicitis · United States.
Among the 78 studies in Appendicitis with a site in United States, this one is the 37th largest by enrollment of the 59 interventional ones that give a count, is one of 6 that started in 2023, is one of 10 in phase 4, and was the 72nd registered.
421 studies on the registry are indexed under Appendicitis; 67 are open to participants now.
Browse Appendicitis studies →6 of the 78 studies in Appendicitis with a site in United States are open now. Recruiting first, the newest first:
True Bearing Diagnostics, Inc. · Sites in United States
Ages 7+ · Healthy volunteers
Cedars-Sinai Medical Center · Sites in United States
Ages 18+
The University of Texas Health Science Center, Houston · Sites in United States
Ages 18+
Ann & Robert H Lurie Children's Hospital of Chicago · Sites in United States
Ages 3–18
Yale University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 39 Appendicitis studies recruiting now, 18 (46%) set no upper age limit and 19 (49%) stop at 75 or younger; 23 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
78 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 6 · Phase 3 3 · Phase 4 10
First in 2003; this study’s year is marked. 6 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 42 is below the median of 116 across 254 interventional studies indexed under Appendicitis.
Median enrollment 98 across the 59 interventional studies, 174 across the 19 observational. Of the 58 that completed or were terminated, 26 (45%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 78 have an industry lead sponsor. The 10 most frequent:
University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.
Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.
University of California, San Francisco has 2 studies filed under Appendicitis — fewer than ten, so there is no comparison to draw.
3 of the studies in Appendicitis with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04039750Prisma Health-UpstateUse of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis | 2026-12 |
| NCT07579312True Bearing Diagnostics, Inc.Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL Study | 2027-04 |
| NCT06395636Ann & Robert H Lurie Children's Hospital of ChicagoEarly Detection of Infection Using the Fitbit in Pediatric Surgical Patients | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 78 studies in Appendicitis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to demonstrate the safety, efficacy, and feasibility of short-course post-operative antibiotic treatment for simple and complicated appendicitis
This is a single center, randomized controlled trial to determine if decreasing the amount of antibiotics after appendicitis surgery can decrease the risk of adverse effects associated with antibiotics while at the same time ensuring participant safety.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age ≥ 18 years
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants undergoing standard of care (SOC) with simple appendicitis will not receive post-operative antibiotics. Participants undergoing standard of care with complicated (gangrenous or perforated) appendicitis will receive up to 24 hours of SOC post-operative antibiotics.
Drug: Multiple standard of care antibiotics for appendicitis, at physicians' discretion
Participants undergoing standard of care with simple appendicitis will receive 24 hours of post-operative SOC antibiotics Participants undergoing standard of care with complicated (gangrenous or perforated) appendicitis will receive 4 days of post-operative SOC antibiotics.
Drug: Multiple standard of care antibiotics for appendicitis, at physicians' discretion
Standard of Care Antibiotic use will be restricted to none or up to 24 hours of post-operative antibiotics.
Standard of Care Antibiotic use will be permitted for 24 hours or up to 4 days of post-operative antibiotics.
Number of Participants With Infectious/Antibiotic Complication
Infectious/antibiotic complication requiring antibiotic treatment only, Emergency Department visit, hospital readmission, percutaneous drainage, and operative intervention as assessed by treating physician.
Time frame: Up to 30 days after appendicitis surgery
Number of Participant Deaths
Up to 30 days after appendicitis surgery
Time frame: Up to 30 days after appendicitis surgery
| Milestone | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group |
|---|---|---|
| Started | 21 | 21 |
| Completed | 21 | 21 |
| Not completed | 0 | 0 |
Infectious/antibiotic complication requiring antibiotic treatment only, Emergency Department visit, hospital readmission, percutaneous drainage, and operative intervention as assessed by treating physician.
| Participants | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group |
|---|---|---|
| Number of Participants With Infectious/Antibiotic Complication | 0 | 1 |
Up to 30 days after appendicitis surgery
| Participants | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group |
|---|---|---|
| Number of Participant Deaths | 0 | 0 |
Collected over Up to 30 days. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Restricted Post-Operative Antibiotics Group | 0/21 (0%) | 0/21 (0%) | 0/21 (0%) |
| Liberal Post-Operative Antibiotics Group | 0/21 (0%) | 0/21 (0%) | 0/21 (0%) |
| Age, Continuous(years) | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group | Total |
|---|---|---|---|
| Mean | 34 ± 13 | 29 ± 7 | 32 ± 11 |
| Sex/Gender, Customized(Participants) | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group | Total |
|---|---|---|---|
| Male | 11 | 15 | 26 |
| Female | 9 | 6 | 15 |
| Transgender | 1 | 0 | 1 |
| Race/Ethnicity, Customized(Participants) | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group | Total |
|---|---|---|---|
| Asian | 2 | 1 | 3 |
| African American | 1 | 0 | 1 |
| Hispanic | 14 | 19 | 33 |
| Native Hawaiian or Other Pacific Islander | 1 | 0 | 1 |
| White | 2 | 1 | 3 |
| Unknown/Not Available | 1 | 0 | 1 |
| Number of Participants who Received Antibiotics in the Emergency Department Prior to Operation(Participants) | Restricted Post-Operative Antibiotics Group | Liberal Post-Operative Antibiotics Group | Total |
|---|---|---|---|
| Count of participants | 16 | 14 | 30 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Patient data will be shared with Denver health and combined with data from other independent sites for final analysis
Supporting information: Study protocol
Time frame: Beginning 9 months and ending 36 months following article publication
Access criteria: Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose
Ran from Jun 2023 to primary completion in Jul 2025, 25 months.
Results were first posted in Oct 2026, 1 year 3 months after primary completion.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco →